ActiCIDP : Exploratory Study on the Feasibility of Predicting CIDP Patients' Evolution Decline During Intravenous Immunoglobulins Treatment Adaptation.
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
ActiCIDP is a monocentric academic study. Patients with Chronic inflammatory demyelinating polyradiculoneuritis may be included on a voluntary basis. The investigators plan to include a group of approximately 40 patients with CIDP. The investigators have planned to assess patient every three months for a year. After each visit, participants will wear Actimyo for one month daily.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:
• Diagnosed with CIDP or possible CIDP based on 2021 EAN/PNS criteria2.
• Treated with IVIg (≤1g/kg/3-8week)
• Clinically Stable disease for 3 months (according to treating physician opinion).
• No treatment withdrawal failure within 1 year
• Age over 18 years
Locations
Other Locations
Belgium
CHR Citadelle
RECRUITING
Liège
Contact Information
Primary
Laurie Medard
laurie.medard@citadelle.be
043215584
Backup
Margaux Poleur, Dr
margaux.poleur@citadelle.be
04216127
Time Frame
Start Date: 2023-08-28
Estimated Completion Date: 2028-01
Participants
Target number of participants: 40
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Universitaire de Liege
Collaborators: SYSNAV, Centre Hospitalier Régional de la Citadelle